EULAR 2025 – Medxy AI

Quality indicators for lupus nephritis care: implementing the 2025 EULAR recommendations — development, adherence, and impact on outcomes

By MedXY 10/16/2026

A validated set of 17 quality indicators (QIs) for lupus nephritis, derived from the 2025 EULAR recommendations, shows variable adherence in practice and an association between higher adherence and lower damage accrual in a tertiary-care cohort.

news Rheumatology

EULAR 2025 Classification Criteria for Haemochromatosis Arthropathy: What Clinicians and Researchers Need to Know

By MedXY 12/04/2025

EULAR’s first-ever, evidence-based classification criteria for haemochromatosis arthropathy (HA) provide an 8-item, 11-point score (≥5 yields 93.3% specificity, 71.4% sensitivity) to standardize research cohorts of C282Y homozygous patients with iron loading and joint disease.